← Back to Discover

EQT Fund Management S.a r.l.

Period ended Sep 30, 2026 · Latest filing Nov 12, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Sep 30, 2026: $947,443,764

More quarters will appear as history becomes available.

Top holdings

Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. WAYSTAR HLDG CORP · COM · 946784105 · shares: $630,444,934
  2. PHARVARIS N V · COM · N69605108 · shares: $108,628,597
  3. OCULIS HOLDING AG · ORDINARY SHARES · H5870P102 · shares: $64,915,746
  4. AGOMAB THERAPEUTICS NV · SPONSORED ADS · 00860C102 · shares: $57,076,111
  5. EVOMMUNE INC · COM SHS · 30054Y107 · shares: $43,681,465
  6. ELECTRA THERAPEUTICS INC · COM · 284825106 · shares: $42,696,911

Reported holdings

6 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
WAYSTAR HLDG CORPCOM946784105 — 24,879,437 shares $630,444,934
PHARVARIS N VCOMN69605108 — 3,424,609 shares $108,628,597
OCULIS HOLDING AGORDINARY SHARESH5870P102 — 6,950,294 shares $64,915,746
AGOMAB THERAPEUTICS NVSPONSORED ADS00860C102 — 5,141,992 shares $57,076,111
EVOMMUNE INCCOM SHS30054Y107 — 5,288,313 shares $43,681,465
ELECTRA THERAPEUTICS INCCOM284825106 — 3,795,281 shares $42,696,911